Sadiya Tanga
Sadiya Tanga has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Basudeb Maji
Bose Institute, Department of Biological Sciences, EN 80, Sector V, Bidhannagar, Kolkata 700091, West Bengal, India
4 shared publications - Arkadeep Karmakar
Bose Institute Department of Biological Sciences EN 80, Sector V, Kolkata Bidhannagar West Bengal 700091 India
3 shared publications - Arpita Hota
Bose Institute Department of Biological Sciences EN 80, Sector V, Kolkata Bidhannagar West Bengal 700091 India
3 shared publications - Anitha Eswari S
Ashoka University Department of Chemistry, Department of Biology Rajiv Gandhi Education City Sonipat Haryana 131029 India
2 shared publications - Mala Thapa
Bose Institute Department of Biological Sciences EN 80, Sector V, Kolkata Bidhannagar West Bengal 700091 India
2 shared publications - Pallabi Das
Bose Institute Department of Biological Sciences EN 80, Sector V, Kolkata Bidhannagar West Bengal 700091 India
2 shared publications
Latest Publications
- 26 December 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (8) , 4159-4172
Tunable naphthalimide-based fluorogenic intracellular nanoaggregates trigger ROS-mediated DNA damage and apoptosis in triple-negative breast cancer cells
Naphthalimide homodimers with tailored linkers control aggregation in cells. Amino acid-linked dimers show strong intracellular aggregation, enhanced emission, ROS generation, DNA damage, apoptosis, and potent anticancer activity against TNBC.
- 26 December 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (8) , 4159-4172
Tunable naphthalimide-based fluorogenic intracellular nanoaggregates trigger ROS-mediated DNA damage and apoptosis in triple-negative breast cancer cells
Naphthalimide homodimers with tailored linkers control aggregation in cells. Amino acid-linked dimers show strong intracellular aggregation, enhanced emission, ROS generation, DNA damage, apoptosis, and potent anticancer activity against TNBC.
- 11 October 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (49)
Engineered Thermostable Chemically Responsive GlowCas9 System for Real‐Time Therapeutic Monitoring Applications
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR‐associated protein (Cas) has revolutionized gene therapy applications due to its ease of design and efficiency, albeit accompanied by off‐target effects. Spatiotemporally regulated Cas9 offers safer gene editing methods due to its lower off‐target mediated genotoxicities; however, probing the Cas9 in real time for assessing the delivery efficiency, gene editing timeframe, and spatial target information remains elusive. Here, we report an engineered Cas9 system, GlowCas9, that can be probed chemically in real‐time across all assay systems, including cell lysate, native gel, ex vivo, and in vivo. Importantly, we rationally engineered the Cas9 system to attain remarkable thermostability with enhanced gene editing activities. Besides its sensitive reporter and enhanced gene editing activity, the GlowCas9 system exhibits precision HDR‐based gene knock‐in ability in cells and significantly outperformed the WTCas9. Overall, we report a new thermostable engineered Sp Cas9 system for real‐time theratracking applications compatible with diverse assay formats, including live ex vivo and in vivo. This GlowCas9 system will add a new dimension of non‐invasive real‐time tracking in gene therapy development, both ex vivo and in vivo.
- 11 October 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (49)
Engineered Thermostable Chemically Responsive GlowCas9 System for Real‐Time Therapeutic Monitoring Applications
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR‐associated protein (Cas) has revolutionized gene therapy applications due to its ease of design and efficiency, albeit accompanied by off‐target effects. Spatiotemporally regulated Cas9 offers safer gene editing methods due to its lower off‐target mediated genotoxicities; however, probing the Cas9 in real time for assessing the delivery efficiency, gene editing timeframe, and spatial target information remains elusive. Here, we report an engineered Cas9 system, GlowCas9, that can be probed chemically in real‐time across all assay systems, including cell lysate, native gel, ex vivo, and in vivo. Importantly, we rationally engineered the Cas9 system to attain remarkable thermostability with enhanced gene editing activities. Besides its sensitive reporter and enhanced gene editing activity, the GlowCas9 system exhibits precision HDR‐based gene knock‐in ability in cells and significantly outperformed the WTCas9. Overall, we report a new thermostable engineered Sp Cas9 system for real‐time theratracking applications compatible with diverse assay formats, including live ex vivo and in vivo. This GlowCas9 system will add a new dimension of non‐invasive real‐time tracking in gene therapy development, both ex vivo and in vivo.
- 11 October 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (49) , e202511707
Engineered Thermostable Chemically Responsive GlowCas9 System for Real‐Time Therapeutic Monitoring Applications
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR‐associated protein (Cas) has revolutionized gene therapy applications due to its ease of design and efficiency, albeit accompanied by off‐target effects. Spatiotemporally regulated Cas9 offers safer gene editing methods due to its lower off‐target mediated genotoxicities; however, probing the Cas9 in real time for assessing the delivery efficiency, gene editing timeframe, and spatial target information remains elusive. Here, we report an engineered Cas9 system, GlowCas9, that can be probed chemically in real‐time across all assay systems, including cell lysate, native gel, ex vivo, and in vivo. Importantly, we rationally engineered the Cas9 system to attain remarkable thermostability with enhanced gene editing activities. Besides its sensitive reporter and enhanced gene editing activity, the GlowCas9 system exhibits precision HDR‐based gene knock‐in ability in cells and significantly outperformed the WTCas9. Overall, we report a new thermostable engineered Sp Cas9 system for real‐time theratracking applications compatible with diverse assay formats, including live ex vivo and in vivo. This GlowCas9 system will add a new dimension of non‐invasive real‐time tracking in gene therapy development, both ex vivo and in vivo.
- 11 October 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (49) , e202511707
Engineered Thermostable Chemically Responsive GlowCas9 System for Real‐Time Therapeutic Monitoring Applications
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR‐associated protein (Cas) has revolutionized gene therapy applications due to its ease of design and efficiency, albeit accompanied by off‐target effects. Spatiotemporally regulated Cas9 offers safer gene editing methods due to its lower off‐target mediated genotoxicities; however, probing the Cas9 in real time for assessing the delivery efficiency, gene editing timeframe, and spatial target information remains elusive. Here, we report an engineered Cas9 system, GlowCas9, that can be probed chemically in real‐time across all assay systems, including cell lysate, native gel, ex vivo, and in vivo. Importantly, we rationally engineered the Cas9 system to attain remarkable thermostability with enhanced gene editing activities. Besides its sensitive reporter and enhanced gene editing activity, the GlowCas9 system exhibits precision HDR‐based gene knock‐in ability in cells and significantly outperformed the WTCas9. Overall, we report a new thermostable engineered Sp Cas9 system for real‐time theratracking applications compatible with diverse assay formats, including live ex vivo and in vivo. This GlowCas9 system will add a new dimension of non‐invasive real‐time tracking in gene therapy development, both ex vivo and in vivo.
- Open Access
- 31 May 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 16 (26) , 12502-12509
Design and synthesis of nucleic acid nano-environment interactome-targeting small molecule PROTACs and their anticancer activity
Small molecule-based nucleic-acid interactome protein degradation through PROteolysis TArgeting Chimeras (PROTACs) is a relatively new modality in cellular interventions.
- 31 May 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 16 (26) , 12502-12509
Open AccessDesign and synthesis of nucleic acid nano-environment interactome-targeting small molecule PROTACs and their anticancer activity
Small molecule-based nucleic-acid interactome protein degradation through PROteolysis TArgeting Chimeras (PROTACs) is a relatively new modality in cellular interventions.